Skip to main content
Log in

Fate and disposition of bromocriptine in animals and man. I: Structure elucidation of the metabolites

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

A total of 16 metabolites of bromocriptine could be isolated from rat bile and incubates of rat liver cell preparations using [6-methyl-14C]bromocriptine as substrate. Separation and purification was achieved by reversed-phase liquid chromatography and preparative thin-layer chromatography in conjunction with radioactivity monitoring. Structure elucidation was based on spectroscopic data (UV, IR, NMR, EI- and FD-MS) and the results of amino acid analysis after acid hydrolysis.

Based on the identified metabolites four principal transformation processes could be described :

  • — Hydrolytic cleavage of the amide bridge leading to the formation of 2-bromolysergic acid amide (3) and 2-bromolysergic acid (7).

  • — epimerization at position 8 of the bromolysergic acid moiety to the iso-derivatives (isobromocriptine, 2-bromo-isolysergic acid (6), its amide (1), etc.)

  • — regiospecific oxidation at position 8′ in the proline fragment generating stereoisomeric 8′-hydroxy-bromocriptines (21–24)

  • — further oxidation of the 8′-hydroxylated derivatives by either the introduction of a second hydroxy group at position 9′ to give dihydroxylated derivatives (detected as conjugates with glucuronic acid: metabolites29, 30 and31), or the opening of the proline ring under formation of the metabolites4 and5 containing glutamic acid instead of proline (7′, 8′-seco-8′-carboxy-bromocriptines).

It is suggested that the primary and principal metabolic attack occurs at the proline fragment of the drug. In contrast to the biotransformation of ergoline compounds, none of the bromocriptine metabolites detected showed oxidative transformations in the lysergic acid half of the molecule.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Thorner, M.O., Flückiger, E., Calne, D.B. (1980): Bromocriptine, a clinical and pharmacological review. Raven Press, New York.

    Google Scholar 

  2. Eckert, H., Kiechel, J.R., Rosenthaler, J. Schmidt, R., Schreier, E. (1978): Biopharmaceutical aspects. Analytical methods, pharmacokinetics, metabolism and bioavailability. In: Berde, B., Schild, H.O. (eds.); Ergot alkaloids and related compounds. Handbook Exp. Pharmacol.49, 719–813; Berlin, Heidelberg, New York: Springer.

    Google Scholar 

  3. Meier, J., Schreier, E. (1976): Human plasma levels of some anti-migraine drugs. Headache16, 96–104.

    Article  CAS  PubMed  Google Scholar 

  4. Voges, R., Schreier, E.: Labelling of bromocriptine with carbon-14 in the 6-methyl group. Sandoz Ltd. Basle, internal reports 1974 and 1979, unpublished.

  5. Seglen, O. (1976): Preparation of isolated rat liver cells. Methods Cell Biol.13, 29–83.

    Article  CAS  PubMed  Google Scholar 

  6. Paul, J. (1975): Cell and Tissue Culture 5th ed., p. 368. Edinburgh, London and New York: Churchill Livingstone.

    Google Scholar 

  7. Maurer, G. (1977): Isolement et structure de métabolites biliaires de la dihydro-β-ergokryptine chez le rat. Thèse de docteur d’état es-sciences présentée devant l’Institut National des Sciences Appliquées de Lyon et l’Université Claude Bernard Lyon I. No d’ordre IDE 77014.

  8. Markey, S.P., Colburn, R.W., Kopin, I.J. Aamodt, R.L. (1979): Distribution and excretion in the rat and monkey of [82Br]bromocriptine. J. Pharmacol. Exp. Ther.211, 31–35.

    CAS  PubMed  Google Scholar 

  9. Wong, S.H., Spencer, R.P., Hosain, P. (1978): Distribution and fate of 2-Br-82-alpha-ergokryptine and H-3-dihydroergokryptine in female rabbits. Fed. Proc.37, 741, Abstract No. 2773.

    Google Scholar 

  10. Stetten, M.R. (1955): Metabolic relationship between glutamic acid, proline, hydroxyproline and ornithine. In: A symposium on amino acid metabolism. Mc Elroy, W.D. and Glass, H.B. (eds). Baltimore: The John Hopkins Press.

    Google Scholar 

  11. Parke, D.V. (1968): The biochemistry of foreign compounds. London: Pergamon Press.

    Google Scholar 

  12. Ho, B., Castagnoli, N. (1980): Trapping of metabolically generated electrophilic species with cyanide ion. Metabolism of 1-benzylpyrrolidine. J. Med. Chem.23, 133–139.

    Article  CAS  PubMed  Google Scholar 

  13. Testa, B., Jenner, P. (1976): Drug metabolism. Chemical and biochemical aspects, pp. 83–97. New York: Marcel Dekker.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maurer, G., Schreier, E., Delaborde, S. et al. Fate and disposition of bromocriptine in animals and man. I: Structure elucidation of the metabolites. European Journal of Drug Metabolism and Pharmacokinetics 7, 281–292 (1982). https://doi.org/10.1007/BF03189631

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189631

key words

Navigation